Exclusive: While HBO has ended its sessions with the current incarnation of “In Treatment,” it’s possible that some of the storylines may continue in another form.
Series, which ran for three seasons on the pay cabler, will not go forward with a fourth. “In Treatment” was based on an Israeli format in which a psychologist saw a range of clients, as well as seeing his own therapist.
HBO is keeping the door open to possible projects involving Gabriel Byrne’s Dr. Paul Weston or some of his patients.
“It’s true that we have no plans to continue with ‘In Treatment’ as previously formatted. However, we are in continued conversations with the executive producers to find another way to continue telling these rich stories,” HBO said in a statement.
It’s unclear whether those storylines would be part of a new version of “In Treatment” or as a completely new series.
What made the show unique was its rotating cast as well as having a new showrunner every year. Byrne appeared in each season as Dr. Weston, who worked out of his home office. Byrne won a Golden Globe in 2009.
Showrunners for final season were Anya Epstein and Dan Futterman, who exec produced with Stephen Levinson, Mark Wahlberg, Paris Barclay and Hagai Levi.
Levi created the show in Israel and remained an exec producer for the show’s U.S. run. Noa Tishby, who was a co-exec producer in the third season, was instrumental in bringing the show from Israel to America. She introduced the series to Levinson, who had a working relationship with HBO at the time with “Entourage.”
The series helped launch the career of Oz actress Mia Wasikowska. Glynn Turman and Dianne Wiest won Emmys for their perfs in the show’s first season as well.
“In Treatment” was never a ratings winner, drawing only 259,000 viewers for its season three premiere.